Clinical Trial Update: Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection [Phase 2]

View source ↗

Summary

Phase 2 pilot trial assessing the efficacy and safety of the fixed-dose combination sofosbuvir/ledipasvir in treatment-experienced patients with hepatitis C gen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• HARVONI (Ledipasvir and Sofosbuvir)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Viral Hepatitis C, HIV | Phase 2 | Status: COMPLETED